While anti-TNF is recommended for sacroiliitis [13], resource limitations, particularly limited access and high cost of biologic drugs [13], lead to alternative combinations of DMARDs and NSAIDs in some countries [7, 31, 32], including Thailand [7, 32]. Here, TNF is linked to Sacroiliac arthritis.